Evidence map›Paper›PMID 23386848›Full record

ArticleFrontiers in immunology2013

Fundamental roles of the innate-like repertoire of natural antibodies in immune homeostasis.

Jaya Vas, Caroline Grönwall, Gregg J Silverman

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 63 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Immunological Aspects of Chytridiomycosis.Journal of fungi (Basel, Switzerland) · 2020
    Review
  11. Observational
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Natural antibodies - facts known and unknown.Central-European journal of immunology · 2018
    Review
  18. Senescent cells expose and secrete an oxidized form of membrane-bound vimentin as revealed by a natural polyreactive antibody.Proceedings of the National Academy of Sciences of the United States of America · 2017
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Jaya VasLaboratory of B Cell Immunobiology, Department of Medicine, New York University School of Medicine New York, NY, USA.
Caroline Grönwall
Gregg J Silverman
New York University · US

Funding

Cell Death and Antibody-Mediated Protection from AutoimmunityR01AI068063 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI SILVERMAN, GREGG JOSHUA · 2006 to 2010
$2.1M
Lupus and the inhibitory dual receptor hypothesisR01AI090118 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI SILVERMAN, GREGG JOSHUA · 2010 to 2014
$2.0M
NIAID NIH HHS R01 AI068063NIAID NIH HHS R01 AI090118
6 · The paper itself

Abstract

The composition of the early immune repertoire is biased with prominent expression of spontaneously arising B cell clones that produce IgM with recurrent and often autoreactive binding specificities. Amongst these naturally arising antibodies (NAbs) are IgM antibodies that specifically recognized amaged and senescent cells, often via oxidation-associated neo-determinants. These NAbs are present from birth and can be further boosted by apoptotic cell challenge. Recent studies have shown that IgM NAb to apoptotic cells can enhance phagocytic clearance, as well as suppress proinflammatory responses induced via Toll-like receptors, and block pathogenic IgG-immune complex (IC)-mediated inflammatory responses. Specific antibody effector functions appear to be involved, as these anti-inflammatory properties are dependent on IgM-mediated recruitment of the early recognition factors of complement. Clinical surveys have suggested that anti-apoptotic cell (AC) IgM NAbs may modulate disease activity in some patients with autoimmune disease. In mechanistic studies, anti-AC NAbs were shown to act in dendritic cells by inhibition of the mitogen-activated protein kinase (MAPK) pathway, a primary signal transduction pathway that controls inflammatory responses. This immunomodulatory pathway has an absolute requirement for the induction of MAPK phosphatase-1. Taken together, recent studies have elucidated the novel properties of a class of protective NAbs, which may directly blunt inflammatory responses through a primitive pathway for regulation of the innate immune system.

Indexed as

immunoregulationinnate-likenatural antibody

Identifiers

PMID23386848
PMCPMC3564042
OpenAlexW2110172316

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.